![Lloyd Damon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lloyd Damon
Corporate Officer/Principal en UCSF Helen Diller Family Comprehensive Cancer Center .
Origen de la red de primer grado Lloyd Damon.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
UCSF Helen Diller Family Comprehensive Cancer Center
![]() UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Part of University of California, UCSF Helen Diller Family Comprehensive Cancer Center is a research, teaching, and patient care center that aims to deliver breakthroughs in cancer treatment. The company is based in San Francisco, CA. The center offers social workers who provide support, problem-solving, and help accessing cancer-related resources to patients.
6
| Subsidiary | Other Consumer Services | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Lloyd Damon a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
American Association for Cancer Research
![]() American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | President Director/Board Member | |
EXELIXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Academy of Medical Sciences
![]() Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TANGO THERAPEUTICS, INC. | Biotechnology | Founder | |
CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Institute of Cancer Research
![]() The Institute of Cancer Research Pharmaceuticals: MajorHealth Technology The Institute of Cancer Research studies the interplay of genes, proteins, and biological processes that drive the development, growth, and spread of cancers. The private company is based in London, UK. The British company focuses on identifying new treatment targets. | Pharmaceuticals: Major | Chief Executive Officer | |
Breakthrough Breast Cancer
![]() Breakthrough Breast Cancer Miscellaneous Commercial ServicesCommercial Services Part of Breast Cancer Campaign, Breakthrough Breast Cancer provides research and development services for breast cancer. The company is based in London, UK. The British company was founded in 1993. Breakthrough Breast Cancer was acquired by Breast Cancer Campaign on June 16, 2015. | Miscellaneous Commercial Services | Director/Board Member | |
European Molecular Biology Organization | Corporate Officer/Principal | ||
University College London | College/University | Doctorate Degree | |
OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Imperial College London | College/University | Undergraduate Degree | |
Catalio Capital Management LP
![]() Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Consultant / Advisor | |
Ambagon Therapeutics, Inc.
![]() Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Biotechnology | Consultant / Advisor | |
GENOMIC HEALTH, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
University of Kansas | College/University | Doctorate Degree | |
Tango Therapeutics Sub, Inc.
![]() Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
BRIDGEBIO PHARMA, INC. | Biotechnology | Founder | |
Navire Pharma, Inc.
![]() Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Melanoma Therapeutics Foundation
![]() Melanoma Therapeutics Foundation Miscellaneous Commercial ServicesCommercial Services Melanoma Therapeutics Foundation supports and researches treatments for melanoma. It provides resources for patients and physicians, supports investigators, and provides new drug development through bridging relationships between academia, pharmaceutical and biotechnology companies. The foundation is headquartered in San Francisco, California | Miscellaneous Commercial Services | Director/Board Member | |
University of Birmingham | College/University | Undergraduate Degree | |
University of Cambridge | College/University | Doctorate Degree | |
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Founder | |
Arresto BioSciences, Inc.
![]() Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Miscellaneous Commercial Services | Director/Board Member | |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Founder | |
AVIDITY BIOSCIENCES, INC. | Biotechnology | Founder | |
PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
National Academy of Sciences
![]() National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PellePharm, Inc.
![]() PellePharm, Inc. BiotechnologyHealth Technology PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
UCSF School of Medicine | College/University | Corporate Officer/Principal | |
BridgeBio Pharma LLC
![]() BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Biotechnology | Founder | |
EXACT SCIENCES CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer |
Estadísticas
Internacional
Estados Unidos | 26 |
Reino Unido | 8 |
Alemania | 2 |
Canadá | 2 |
Bélgica | 2 |
Sectorial
Health Technology | 20 |
Commercial Services | 8 |
Consumer Services | 7 |
Finance | 2 |
Electronic Technology | 2 |
Operativa
Director/Board Member | 17 |
Corporate Officer/Principal | 10 |
Founder | 7 |
Independent Dir/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Las relaciones más conectadas
Insiders | |
---|---|
Francis McCormick | 21 |
Alan Ashworth | 14 |
Frederick Baehner | 4 |
Hope S. Rugo | 1 |
Adil Daud | 1 |
Teri Melese | 1 |
- Bolsa de valores
- Insiders
- Lloyd Damon
- Conexiones Empresas